Home
Forums
ACS & AMI
Angiomyogenesis & Cell Therapy
Carotid Interventions
Imaging
Complex Coronary Interventions
Chronic Total Occlusion
Drug-Eluting Stents
Emerging Devices & Innovative Therapies
Nurse & Tech Corner
Peripheral Interventions
Vulnerable Plaque
Workshop with the FDA
Clinical Trials
Taxus Stent
PROVE IT
PARIS
EVEROLIMUS FUTURE I & II
ENDEAVOR
BIAMI
SIROLIMUS and Analogues
EVEREST I
ISAR-REACT
REPLACE-2
SYNERGY
Library
Washington Heart Monitor Archives
Abstracts
Slide Presentations
Cardiovascular Marketplace
Poll Archives
Meetings
CRT (Cardiovascular Research Technologies)
ACC (American College of Cardiology)
AHA (American Heart Association)
TCT (Transcatheter Cardiovascular Therapeutics)
ESC (European Society of Cardiology)
EuroPCR
Washington Hospital Center Cardiology Meetings
SCAI
Login
ACS & AMI
Angiomyogenesis & Cell Therapy
Carotid Interventions
Imaging
Complex Coronary Interventions
Chronic Total Occlusion
Drug-Eluting Stents
Emerging Devices & Innovative Therapies
Nurse & Tech Corner
Peripheral Interventions
Vulnerable Plaque
Workshop with the FDA
Clinical Trials
-> ISAR-REACT
4/25/2006
Glycoprotein IIb/IIIa Inhibition With Abciximab in Patients Undergoing Coronary Stenting After Pretreatment With a High Loading Dose of Clopidogrel
Kastrati
Copyright © 2010, CRTONLINE -
About / Contact Us
. All rights reserved.
Privacy Policy
Powered by
Multiweb
